Stryker Strikes It Again
Suman Chatterjee
•
Thu, Oct 20, 2011
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
19 people get VITA articles and Market Currents by email alert.
Get email alerts on VITA »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
Merger Arbitrage Mondays: July 4, 2011Asif Suria • Mon, Jul 4, 2011 -
-
Stryker Buys Orthovita With CashZacks Investment Research • Wed, May 18, 2011 -
Orthovita Inc. Q1 2010 Earnings Call TranscriptTue, May 4, 2010
-
-
-
Three Top and Bottom Market Sectors for This WeekJ Clinton Hill • Sun, Jun 21, 2009
-
-
-
-
Orthovita Showing Some SpineThe Correct Call • Wed, Nov 19, 2008 -
Orthovita, Inc. Q3 2008 Earnings Call TranscriptMon, Nov 10, 2008
To learn more about Seeking Alpha Pro, click here.
-
-
Orthovita Showing Some SpineThe Correct Call • Wed, Nov 19, 2008
-
Stryker Strikes It AgainSuman Chatterjee • Thu, Oct 20, 2011
-
Merger Arbitrage Mondays: July 4, 2011Asif Suria • Mon, Jul 4, 2011
-
-
Stryker Buys Orthovita With CashZacks Investment Research • Wed, May 18, 2011
-
-
-
Three Top and Bottom Market Sectors for This WeekJ Clinton Hill • Sun, Jun 21, 2009
-
-
-
Orthovita Inc. Q1 2010 Earnings Call TranscriptTue, May 4, 2010
-
Orthovita, Inc. Q3 2008 Earnings Call TranscriptMon, Nov 10, 2008
-
at MarketWatch.com (May 16, 2011)
-
at MarketWatch.com (May 16, 2011)
-
at MarketWatch.com (May 16, 2011)
VITA vs. ETF Alternatives
Company Description
Currently, there's no company description for VITA.
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Monday, June 6, 2011, 12:24 PM Medical device maker Stryker (SYK -1.3%) makes a bigger move into the hand-and-foot market by agreeing to acquire Memometal Technologies for at least $150M. Stryker's countering flat sales with acquisitions; last month it agreed to buy Orthovita (VITA) for about $304M. Comment! [Healthcare, M&A]
- Monday, May 16, 2011, 9:23 AM Stryker (SYK) signs a definitive agreement to acquire orthobiologic and biosurgery product maker Orthovita (VITA) for ~$304M in cash. Shareholders will receive $3.85/share, a 41% premium over Friday's close. The deal also includes $12M in debt. VITA +40.3% premarket. (PR) Comment! [M&A, Healthcare]
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
LATEST REPLIES